
Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease
Author(s) -
Carsten Gnewuch,
Gerhard Liebisch,
Thomas Langmann,
Benjamin Dieplinger,
Thomas Mueller,
Meinhard Haltmayer,
Hans Dieplinger,
Alexandra Zahn,
Wolfgang Stremmel,
Gerhard Rogler,
Gerd Schmitz
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.3134
Subject(s) - tauroursodeoxycholic acid , fgf19 , glycocholic acid , ursodeoxycholic acid , chenodeoxycholic acid , bile acid , gastroenterology , medicine , ulcerative colitis , cholic acid , deoxycholic acid , inflammatory bowel disease , lithocholic acid , primary sclerosing cholangitis , taurocholic acid , enterohepatic circulation , bile acid malabsorption , chemistry , disease , biochemistry , receptor , endoplasmic reticulum , unfolded protein response , fibroblast growth factor
To determine free and conjugated serum bile acid (BA) levels in inflammatory bowel disease (IBD) subgroups with defined clinical manifestations.